Copyeditor – Medical Affairs Quality

Scientific data and information are core assets of Lilly. Providing balanced, objective, and accurate information to regulators, the scientific community, health care professionals (HCPs), payers, and patients in a consistent and timely fashion across the entire drug development lifecycle is fundamental to Lilly. As HCPs are deluged with data and are making choices in an increasingly complex and stressed health system, Lilly Medical Affairs (MA) can provide clear, credible answers that will set Lilly apart from its competitors. MA mission is to make Lilly the preferred pharmaceutical partner in the healthcare community globally by leveraging its medical expertise to drive patient-centric answers and solutions. MA brings deep medical expertise to HCPs and payers and focuses on answering HCP questions with customized clinical and real-world evidence that can make the difference on if and how they use Lilly products. Additionally, MA brings clinical insights from customers back to Lilly to inform new product development and lifecycle planning. MA also supports patients with educational tools to help them manage their illness and with assistance to access our medicines for those facing tough financial situations.